In addition to diagnostics and clinical-pathological classification into superficial spreading, nodular, lentigo maligna, and acrolentiginous melanomas (Mooi and Krausz 2007), recent molecular diagnostics can delineate subtypes of melanoma (possessing mutations in BRAF, NF1, RAS, or triple wild type) (The Cancer Genome Atlas Network 2015). Here, BRAF is linked to melanoma.